---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-000968"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2026-01-02T23:59:59+00:00"
generated_at: "2026-05-16T11:48:02.453519+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Eledon exchanges 4.2M shares for pre-funded warrant with Coastlands

## Summary
- Exchange of 4,203,764 common shares for pre-funded warrant at $0.001 exercise price.
- Warrant has 4.99% beneficial ownership limitation, can be increased to 19.99% per Nasdaq rules.
- Issued under Section 3(a)(9) exemption; exchange closed December 30, 2025.
- Counterparty: Coastlands Capital Partners LP.

## SEC filing metadata
- accession: 0001193125-26-000968
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2026-01-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000119312526000968/0001193125-26-000968-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000119312526000968/eldn-20251230.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-000968
- JSON: https://secwatch.observer/filing/0001193125-26-000968.json
- Plain text: https://secwatch.observer/filing/0001193125-26-000968.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.